Excited to join @oNKo_innate in Jan 2022 & have the opportunity to contribute to their important, cutting-edge #cancerImmunotherapy discoveries! Great to still work with the same amazing & brilliant scientists I have been learning so much from @JoeCursons @Dr_Nick_Bikes
Many congratulations to @Dr_Nick_Bikes @oNKo_innate team. Always a joy working with you and here’s to your continued exponential growth! Exemplar of academia and entrepreneurship working together. https://twitter.com/AusBiotech/status/1453131871722737664
Fantastic recognition of the @oNKo_innate team & the potential for their platform & pipeline to shape future cancer immunotherpies. Huge kudos to Jai Rautela @DrIvaNikolic @JoeCursons @richberry1983 @chaks86 & thier teams for the cutting edge science, dedication & vision 👏 https://twitter.com/AusBiotech/status/1453131871722737664
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
